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Abstract
Introduction: As global policy evolves toward initiating lifelong antiretroviral therapy (ART) regardless of CD4 count, initiating
individuals newly diagnosed with HIV on ART as efficiently as possible will become increasingly important. To inform progress, we
conducted a systematic review of pre-ART interventions aiming to increase ART initiation in sub-Saharan Africa.
Methods: We searched PubMed, Embase and the ISI Web of Knowledge from 1 January 2008 to 1 March 2015, extended in
PubMed to 25 May 2016, for English language publications pertaining to any country in sub-Saharan Africa and reporting on
general adult populations. We included studies describing interventions aimed at increasing linkage to HIV care, retention in pre-
ART or uptake of ART, which reported ART initiation as an outcome. We synthesized the evidence on causal intervention effects
in meta-analysis of studies belonging to distinct intervention categories.
Results and discussion: We identified 22 studies, which evaluated 25 interventions and included data on 45,393 individual
patients. Twelve of twenty-two studies were observational. Rapid/point-of-care (POC) CD4 count technology (seven interventions)
(relative risk, RR: 1.26; 95% confidence interval, CI: 1.021.55), interventions within home-based testing (two interventions) (RR:
2.00; 95% CI: 1.362.92), improved clinic operations (three interventions) (RR: 1.36; 95% CI: 1.251.48) and a package of patient-
directed services (three interventions) (RR: 1.54; 95% CI: 1.201.97) were all associated with increased ART initiation as was HIV/
TB service integration (three interventions) (RR: 2.05; 95% CI: 0.597.09) but with high imprecision. Provider-initiated testing
(three interventions) was associated with reduced ART initiation (RR: 0.91; 95% CI: 0.860.97). Counselling and support
interventions (two interventions) (RR 1.08; 95% CI: 0.941.26) had no impact on ART initiation. Overall, the evidence was graded
as low or moderate quality using the GRADE criteria.
Conclusions: The literature on interventions to increase uptake of ART is limited and of mixed quality. POC CD4 count and
improving clinic operations show promise. More implementation research and evaluation is needed to identify how best to offer
treatment initiation in a manner that is both efficient for service providers and effective for patients without jeopardizing
treatment outcomes.
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Introduction
A persistent challenge confronting national HIV care and
treatment programmes in low- and middle-income countries
is late initiation of antiretroviral therapy (ART) and high
patient attrition between HIV testing and treatment initia-
tion. A recent systematic review found no significant change
in CD4 cell counts at ART initiation in sub-Saharan Africa
between 2002 and 2013, with the median remaining well
below 200 cells/mm3-the original (and lowest) threshold for
treatment eligibility [1]. The first published systematic review
of retention in pre-ART care in sub-Saharan Africa estimated
that 40% of patients testing positive for HIV were not linked
to care to learn if they were eligible for treatment, and
30% who were eligible never started treatment [2]. Later
systematic reviews have confirmed these findings of high
rates of patient attrition before starting treatment despite
eligibility under the prevailing threshold [35].
As global and national guidelines evolve toward initiating
lifelong ART for all patients testing positive for HIV, regardless
of CD4 cell count [6], the number of diagnosed patients who
are not eligible for ART will diminish rapidly. The challenge of
retaining patients in pre-ART care will lose its importance, to
be replaced by the challenge of initiating on ART individuals
newly diagnosed with HIV as efficiently as possible  in other
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words, maximizing the proportion of patients who do start
treatment promptly, while minimizing the costs to both
patients and the healthcare system. In recent years, a
number of interventions have been developed and imple-
mented that aim to increase uptake of ART for patients
known or found to be eligible. To help inform continued
progress in this area, we conducted a systematic review of
the literature from 2008 to 2015 of pre-treatment interven-
tions that reported the effect of the intervention on ART
initiation in sub-Saharan Africa.
Methods
This review is drawn from a larger systematic review of
interventions to facilitate linkage to care and ART initiation
conducted to support development of the World Health
Organization’s 2015 Consolidated Guidelines for the Use of
Antiretroviral Drugs for Treating and Preventing HIV Infection
and completed in June 2015. We include here the subset of
articles in that review that were conducted in sub-Saharan
Africa and reported rates and/or timing of ART initiation as
an outcome.
Search strategy and inclusion criteria
We included in the review randomized controlled trials,
quasi-experimental trials, observational cohort studies and
programme evaluations describing interventions to improve
linkage to or retention in pre-ART care or to improve uptake
of ART for those eligible. We searched for studies published
or presented in English in 2008 or later pertaining to any
country in sub-Saharan Africa and reported on general adult
populations. Studies explicitly enrolling high-risk populations
(e.g. sex workers) were excluded, as were those of interven-
tions to improve initiation of ART for pregnant women in
prevention of mother-to-child transmission programmes, as
these comprise a different programmatic area than general
HIV care. We limited the review to studies that included a
comparison with standard of care (acknowledging that stan-
dard of care varies across settings), so that the effect size
could be estimated and would be relevant to routine practice.
We required that each study report an effect estimate for the
intervention or risk/rates of outcomes between the two
groups compared. Finally, as noted above, we required that
each study report an outcome of an effect on the rate or
timing of ART initiation. We accepted each article’s own
definition of ‘‘initiation’’ but presume that in nearly every
case it referred to a patient being prescribed or dispensed an
initial supply of ARVs.
To identify studies, we searched PubMed, Embase and the
ISI Web of Knowledge from 1 January 2008 to 1 March 2015,
for English language publications. Within each index, we
combined ‘‘HIV’’ or ‘‘ART’’ with any of ‘‘linkage,’’ ‘‘pre-ART,’’
‘‘initiation,’’ ‘‘retention,’’ ‘‘attrition,’’ ‘‘adherence,’’ ‘‘loss to
follow-up’’ or ‘‘patient compliance’’ and any of ‘‘efficacy,’’
‘‘evaluation,’’ ‘‘intervention’’ or ‘‘trial’’ (Supplementary file 1).
To find relevant abstracts, we manually searched conference
sessions on linkage to care and retention in care at AIDS and
IAS conferences from 2008 to 2015 and CROI 2014 and 2015
(CROI abstracts from earlier years are not available). To
identify sources missed by these methods, we searched
reference lists of review articles identified through electronic
database searches. PubMed was also searched to determine
if conference abstracts have been published as full articles.
We then screened the articles that met the criteria for
inclusion in the larger review for results pertaining to ART
initiation, sub-Saharan Africa and adults. Finally, we updated
the search for publications between 1 March 2015 and 25
May 2016 using a targeted search strategy focusing on
initiation, using the search syntax [(HIV OR ‘‘antiretroviral
therapy’’) AND (initiation) AND (efficacy OR evaluation OR
intervention OR trial) AND (Africa)] in PubMed and manually
searched abstracts presented at IAS 2015 and CROI 2016.
MPF conducted the primary search and SR conducted the
targeted search. After excluding those whose titles were
not relevant, abstracts were read to determine eligibility.
Full-text articles were reviewed by both authors to confirm
eligibility. Uncertainties were resolved through consensus of
both authors. We did not contact the authors of studies for
primary data.
Analysis
After extracting a standard set of indicators from each article,
we first described the interventions included as to country,
population, intervention, dates and outcomes. We then
grouped the interventions by major approach into seven
categories: counselling and support, HIV/TB integration,
interventions within provider-initiated HIV testing, home-
based HIV self-testing, use of a rapid/point-of-care (POC)
CD4 count, improved clinic operations and implementing a
package of patient-centred services. Where an intervention
could arguably be assigned to more than one category, we
chose the one that captured the aspect of the intervention
most emphasized by the authors. Although the categories
represent roughly similar approaches, interventions within
categories and the methods used to evaluate them were
heterogeneous, and category results should be interpreted
with caution. By category, we estimated the measure of effect
for each study with corresponding 95% confidence intervals
(CIs) as reported, or when not reported, as calculated from
the data.
We assessed the quality of the body of studies in each
category of interventions using the GRADE methodology [7].
We noted that because many of the studies reviewed were
observational in nature, few were expected to be considered
high quality using the GRADE methodology. We then con-
ducted a random-effects meta-analysis for each category to
estimate a summary relative risk (RR) and 95% CI for each
category of interventions. For each, we present the results,
relative weights and the corresponding I2 values.
Results
Our primary search, illustrated in Figure 1, identified a total
of 8248 full-text articles and abstracts. After an initial screen
of the titles and abstracts, 409 citations met our initial
screening criteria. Upon further review, 136 were deemed
relevant for full-text review. Of these, 22 met all the inclusion
criteria and were included in the final review.
The 22 included studies, which evaluated 25 interventions,
are described in Table 1. They included data on 45,393
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individual patients. Nine countries were represented, all in
eastern or southern Africa. Three studies enrolled both adult
and paediatric patients as defined by the studies, while the
rest enrolled only adults. All of the studies were published in
2010 or later, with a large proportion (55%, 12/22) published
in 2014 or later, signalling a recent rise in attention to this
issue. About 55% (12/22) of the studies included were
observational in nature with either pre-post (36%, 8/22) or
parallel (18%, 4/22) designs. The remaining 45% (10/22) were
randomized trials, primarily individually randomized trials
(32%, 7/22).
The interventions evaluated in each study, the outcomes
assessed and the results as grouped by the authors are
presented in Table 2. Table 3 presents our assessment of the
quality of evidence and meta-analysis results by category of
intervention. Below, we summarize results for each category
of interventions and the evidence for each as shown in Tables
13. Effects of all the interventions are synthesized using a
random effect meta-analysis in Figure 2. Forest plots for each
set of interventions with corresponding weights and I2 values
are given in Supplementary file 2.
Counselling and support interventions
We identified five counselling and support interventions
evaluated in four studies, all conducted in South Africa and/
or Uganda. In total, the studies included 2951 individuals.
All were individually randomized trials. The interventions
were lay counsellor home visits after a home-based CD4
count [8]; lay counsellor clinic visit facilitation [8]; home
visits, calls and text messages by patient navigators [9]; home
visits by peer supporters [10]; and provision of an informa-
tional brochure to patients explaining how to obtain further
care [11]. Rates of ART initiation among control-arm patients
eligible for treatment were low, at only 32% when pooled
across the four studies. Only one of the four interventions,
lay counsellor home visits, had a significant positive effect
with a risk difference of 7% (RR [95% CI] 1.23 [1.031.46]) [8].
Our meta-analysis estimated that the counselling and support
interventions included in the review had little to no im-
pact on ART initiation (RR 1.08; 95% CI: 0.941.26). Because
all four studies were randomized trials, this was the inter-
vention category with the overall best quality and was graded
as moderate quality, as shown in Table 3.
HIV/TB integration
We found three studies that reported on interventions to
integrate HIV and TB services. One was a cohort study in
South Africa that examined co-locating HIV and TB services
(referred to as ‘‘semi-integrated’’) [12], while two were pre
post studies of fully integrated HIV and TB services, one
in Uganda [13] and one in the Democratic Republic of
Congo [14]. In total, the three studies included 1695 subjects.
Two of the three studies showed a large benefit. When
pooled across the three studies, rates of ART initiation were
moderate in the control arm (39%). When combined in
a meta-analysis, HIV/TB service integration was associated
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identified through other
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Figure 1. Flow chart of included and excluded studies (as per PRISMA).
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Table 1. Characteristics of studies included in the review
Publication Location Study
Study ID Type Year Country Sites Design Population Data collection Starting point Ending point
Counselling/support
Barnabas 1 [8] Article 2016 South Africa and
Uganda
KwaZulu-Natal and Sheema
Districts
Individually
randomized trial
HIV-positive patients at home-
based testing
June 2013 to Feb
2015
HIV testing ART initiation
Barnabas 2 [8] Article 2016 South Africa and
Uganda
KwaZulu-Natal and Sheema
Districts
Individually
randomized trial
HIV-positive patients at home-
based testing
June 2013 to Feb
2015
HIV testing ART initiation
Bassett [9] Abstract 2015 South Africa Two hospital outpatient
departments and two
primary health clinics
Individually
randomized trial
Adults newly testing HIV positive
and ART eligible
HIV testing On ART three
months
Chang [10] Article 2015 Uganda Rakai District Individually
randomized trial
Adults HIV positive not on ART June 2011 to July
2013
HIV testing ART initiation
Faal 1 [11] Article 2011 South Africa One urban primary
healthcare clinic (Esselen
clinic) in the inner city of
Johannesburg
Individually
randomized trial
Adults newly testing HIV positive
and ART eligible
Aug to Dec 2009 HIV testing ART initiation
HIV/TB integration
Louwagie [12] Article 2012 South Africa 46 TB treatment points in
Tshwane, South Africa
Cohort study Adults HIV positive with TB who
were ART eligible
Oct 2008 to Mar
2009 (enrolment)
HIV testing ART initiation
Hermans [13] Article 2012 Uganda The Infectious Diseases
Institute at Makerere,
University College of Health
Sciences in Kampala, Uganda
Pre/post cohort
study
Adults HIV positive with TB 2007 and 2009 TB treatment
initiation
ART initiation
Van Rie [14] Article 2014 Democratic Republic
of Congo (DRC)
5 clinics in Kinshasa, DRC Pre/post cohort
study
Adults HIV positive with TB Jan 2006 to Nov 2009 HIV testing ART initiation
Provider-initiated counselling and testing
Clouse [15] Article 2014 South Africa Witkoppen Health and
Wellness Centre
Pre/post cohort
study
Adults newly testing HIV positive
and ART eligible
Jan 2010 to July 2012
(enrolment)
HIV testing ART initiation
Topp [16] Article 2012 Zambia Seven urban-integrated
primary care clinics
Cohort study Adults and children newly testing
HIV positive and ART eligible
July 2008 to June
2011
HIV testing ART initiation
Interventions within home-based HIV testing
Desai [17] Abstract 2015 Kenya 2 rural districts of Western
Kenya
Cluster-
randomized trial
Adults newly testing HIV positive July 2013 to Feb 2014
(enrolment)
HIV testing ART initiation
MacPherson [18] Article 2014 Malawi Multiple sites in Blantyre,
Malawi
Cluster-
randomized trial
Adults (all) in the study clusters Jan 30 to Nov 5, 2012 HIV testing ART initiation
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Table 1 (Continued )
Publication Location Study
Study ID Type Year Country Sites Design Population Data collection Starting point Ending point
Rapid/point-of-care CD4 count technology
Barnabas 3 [8] Article 2016 South Africa and
Uganda
KwaZulu-Natal and Sheema
Districts
Individually
randomized trial
HIV-positive patients at home-
based testing
June 2013 to Feb
2015
HIV testing ART initiation
Faal 2 [11] Article 2011 South Africa One urban primary health
care clinic (Esselen clinic) in
the inner city of Johannesburg
Individually
randomized trial
Adults newly testing HIV positive
and ART eligible
Aug to Dec 2009 HIV testing ART initiation
Jani [19] Article 2011 Mozambique Four public primary health
clinics in the Maputo and
Sofala provinces
Cohort study Enrolled adults and children
getting a blood draw for CD4
staging
2009 CD4 staging
completion
ART initiation
Nicholas [20] Abstract 2015 Malawi Rural decentralized health
centres in Chiradzulu District,
Malawi
Cohort study Adults and children July 2013 to Oct 2014 CD4 blood
draw
ART initiation
Larson [21] Article 2013 South Africa Themba Lethu Clinic,
Johannesburg
Pre/post cohort
study
Adults newly testing HIV positive Jan 2008 to July 2010 HIV testing ART initiation
Matambo [22] Abstract 2012 South Africa Musina Sub-District Pre/post cohort
study
Adults newly testing HIV positive July 2009 to Dec
2011
HIV testing ART initiation
Moyo [23] Abstract 2015 Botswana Six rural clinics in Tutume Pre/post cohort
study
Jan 2013 to Feb 2014 ART initiation
Improved clinic operations
Fairall [24] Article 2012 South Africa 31 primary care clinics in the
Free State Province
Cluster-
randomized trial
Adults HIV positive not on ART but
eligible or approaching eligibility
Jan 28, 2008 to June
30, 2010
CD4 staging
completion
ART initiation
Pfeiffer [25] Article 2010 Mozambique 12 clinics in Sofala and
Manica Provinces
Pre/post cohort
study
Adults eligible for ART 2004 to 2007 ART eligibility ART initiation
Rosen [26] Article 2016 South Africa Two public sector outpatient
clinics in Johannesburg
Individually
randomized trial
Adults newly testing HIV positive Apr 2013 to Aug
2014 (enrolment)
HIV testing ART initiation
Package of patient services
Burtle [27] Article 2012 Swaziland Good Shepherd Hospital, the
district referral hospital for
the Lubombo region
Pre/post cohort
study
Adults eligible for ART Feb 2009 to Feb 2010
(enrolment)
ART eligibility ART initiation
Siedner [28] Article 2015 Uganda Mbarara, Uganda Pre/post cohort
study
Adults HIV positive Jan 2012 to Nov 2013 CD4 blood
draw
ART initiation
Wanyenze [29] Article 2013 Uganda Mulago Hospital, Uganda Individually
randomized trial
Adults newly testing HIV positive
and ART eligible
May 2008 to June
2011 (enrolment)
ART eligibility ART initiation
ART initiation indicates that at least the first dose of ARV medications has been prescribed or dispensed.
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Table 2. Reported results of included studies
Study ID Intervention Comparison Outcome
Timing of
outcome
N
intervention
(control)
Risk/rate
intervention
(control) Effect size
95%
confidence
interval p Interpretation
Counselling and support
Barnabas 1 Clinic visit facilitation Standard of care
referral
ART
initiation
431 (423) 0.37 (0.34) RR 1.11 0.921.34 0.26 Clinic visit facilitation was not
associated with any difference
in ART initiation
Barnabas 2 Lay counsellor home follow-up Standard of care
referral
ART
initiation
449 (423) 0.41 (0.34) RR 1.23 1.021.47 0.028 Lay counsellor follow-up was
associated with an increase in
ART initiation
Bassett Patient navigators using a
strengths-based case-
management approach and
scheduled phone calls and text
messages over four months
Standard of care On ART for
those ART
eligible
Three months
on ART
618 (528) 0.34 (0.37) RR 0.92a 0.791.07a 0.6 This approach to patient
navigation was not associated
with an increase in linkage to
care
Chang Peer supporters with monthly
visits to provide support and
counselling
Standard of care Currently
on ART
One year 216 (215) 0.32 (0.30) RR 1.09 0.811.45 This approach to peer support
was not associated with an
increase in treatment initiation
Faal 1 Immediate receipt of CD4 count
results (FACSCount)
Standard collection of
CD4 result only
ART
initiation
One month 35 (36) 0.37 (0.25) RR 1.49a 0.373.03a Leaflets were not associated
with a significant increase in
ART initiation among those
ART eligible.
HIV/TB integration
Hermans Integrated TB/HIV care and
treatment
Standard of care ART
initiation
243 (228) 0.57 (0.66) RR 0.86 0.751.0a 0.034 ART and TB treatment
integration did not lead to an
increase in ART initiation
Louwagie ART and TB care at same site
(‘‘semi-integrated’’)
Geographically
separately rendered
HIV and TB care
ART
initiation
105 (233) 0.71 (0.45) sHR 2.49 1.065.88 ART and TB treatment under
one roof was associated with
an increase in ART initiation for
HIV-positive TB patients
Van Rie Integrated TB/HIV care and
treatment
Standard of care
referral to centralized
ART facility after
diagnosis
ART
initiation
513 (373) 0.69 (0.17) RR 4.06a 3.215.13a Integrated services was
associated with an increase in
ART initiation
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Table 2 (Continued )
Study ID Intervention Comparison Outcome
Timing of
outcome
N
intervention
(control)
Risk/rate
intervention
(control) Effect size
95%
confidence
interval p Interpretation
Provider-initiated HIV testing
Clouse Systematic opt-out HCT for all
adult clients
Targeted PICT and
voluntary counselling
and testing
ART
initiation
Twelve months
after diagnosis
717 (744) 0.64 (0.59) RR 1.08a 1.001.18a 0.05 Systematic opt-out HCT was
associated with a small
increase in ART initiation
among those ART eligible
Topp Provider-initiated testing and
counselling for adults and
children
Voluntary counselling
and testing
ART
initiation
1655 (6520) 0.72 (0.69) aOR 0.9 0.820.97 0.01 Integrated care was associated
with a small decrease in the
odds of being initiated on ART
if eligible
Interventions combined with home-based HIV testing
Desai POC CD4 count at home-based
HIV testing with referral
Standard of care
home-based HIV
testing and referral
ART
initiation
371 (321) 0.17 (0.10) RR 1.65a 1.112.54a 0.01 POC CD4 during home-based
HCT was associated with an
increase in ART initiation
MacPherson HIV self-testing followed by
optional home initiation of HIV
care
HIV self-testing
accompanied by
facility-based HIV
care
ART
initiation
Six months 8194 (8466) 0.022 (0.007) aRR 2.44 1.613.68 B0.001 HIV self-testing followed by
optional home initiation was
associated with a significant
increase in ART initiation
over six months among all
testers
Rapid/Point-of-care CD4 count
Barnabas 3 POC CD4 count (Pima) Standard of care
referral
ART
initiation
627 (676) 0.39 (0.36) RR 1.08 0.941.26 0.28 POC CD4 count staging was
not associated with a
significant increase in ART
initiation
Faal 2 Same day CD4 count results
(FACSCount)
Standard collection of
CD4 result only
ART
initiation
One month 43 (36) 0.65 (0.25) RR 2.1 1.393.17 Same day receipt of CD4
counts was associated with a
significant increase in ART
initiation among those ART
eligible.
Jani POC CD4 count (Pima) Standard of care lab
referral of blood for
CD4 staging
ART
initiation
437 (492) 0.65 (0.61) OR 1.07a 0.871.30a POC CD4 count staging was
not associated with a
significant increase in ART
initiation among those eligible
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Table 2 (Continued )
Study ID Intervention Comparison Outcome
Timing of
outcome
N
intervention
(control)
Risk/rate
intervention
(control) Effect size
95%
confidence
interval p Interpretation
Larson Same day CD4 count results
(FACSCount)
Standard of care ART
initiation
516 weeks 273 (223) 0.49 (0.46) aRR 1.2 0.991.46 0.06 Rapid POC CD4 results
were associated with a small
non-significant increase in
ART initiation among
eligible
Matambo Integrated mobile HIV/TB
primary health care with POC
CD4 testing (Pima)
Standard of care ART
initiation
226 (380) 0.83 (0.51) RR 1.63a 1.451.83a B0.0001 Integrated services was
associated with an increase in
linkage to care
Moyo Point-of-care CD4 count (Pima) Standard of care ART
initiation
RR 1.33 0.01 POC led to an increase in ART
initiation
Nicholas Point-of-care CD4 count (Pima) Standard of care ART
initiation
Any time 253 (259) RR 0.96 0.911.01 POC led to no overall increase
in ART initiation among those
eligible
Improved clinic operations
Fairall Prescribing nurses given
educational outreach training
sessions about ART prescribing
and task shifting to nurses
Standard of care ART
initiation
At least 12
months
5390 (3862) 0.69 (0.63) RR 1.24b 0.881.73 0.218 Training and task shifting to
nurses was associated with a
small non-significant increase
in ART initiation
Pfeiffer HIV service integration including
co-location of services; training
personnel to provide multiple
services; training to link
separate services; strengthening
linkages between facility levels;
and harmonization of data
collection
Standard of care ART
initiation
590 days of
eligibility
RR 1.58 1.172.14 HIV service integration was
associated with an increase
in ART initiation
Rosen Immediate (rapid) ART initiation
including POC technology
and service delivery
acceleration
Standard of care ART
initiation
590 days after
testing HIV
positive and
ART eligible
187 (190) 0.97 (0.72) RR 1.36 1.251.49 Immediate ART initiation was
associated with an increase
in uptake of ART within
90 days
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Table 2 (Continued )
Study ID Intervention Comparison Outcome
Timing of
outcome
N
intervention
(control)
Risk/rate
intervention
(control) Effect size
95%
confidence
interval p Interpretation
Package of patient services
Burtle Introduction of pre-ART
interventions, including task
shifting, counselling, clinical
staging, timely ART initiation,
social and psychological support
Standard of care ART
initiation
419 (68) 0.81 (0.53) RR 1.53a 1.221.92a The intervention was
associated with a 50% increase
in ART initiation among those
ART eligible
Siedner SMS notifying patients of CD4
results; if early return to clinic
required, one of three messages
and transport reimbursement
Standard of care ART
initiation
110 (26) 0.96 (0.81) aHR 2.26 1.383.73 0.001 SMS notification was
associated with a significant
increase in ART initiation
Wanyenze Enhanced linkage with case-
management referral
(counselling, assisted disclosure
of HIV status, staff introduction
and scheduling, reminder via
telephone or home visit one
week before the scheduled
appointment) and tracing of lost
patients
Standard linkage to
care (explanation of
services, hours, and
locations of the
clinics nearby)
ART
initiation
among
those
eligible
One year 202 (183) 0.78 (0.71) aHR 1.29c 1.031.67c 0.03 Enhanced linkage was
associated with a significant
increase in ART initiation
among those eligible
RR, relative risk; aRR, adjusted relative risk; aIRR, adjusted incidence rate ratio; OR, odds ratio; aOR, adjusted odds ratio; aHR, adjusted hazard ratio; PR, prevalence ratio.
aRelative risk and 95% CI not reported but approximated from the data. bAdjusted for clustering. cPresenting the invers of the results (i.e. 1/(results presented)) as the comparison provided was the effect
of standard of care vs. intervention.
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Table 3. GRADE quality assessment and random effects meta-analysis of categories of interventions to improve ART initiation
Risk of:
Random effects
# (type) studies Bias Inconsistency Indirectness Imprecision N intervention (control) Risk intervention (control) meta-analysis relative risk (95% CI) Quality
Counselling and support
5 (5 iRCT)a Not serious Not serious Not serious Not serious 1749 (1202) 0.34 (0.32) 1.08 (0.941.26) Moderateb
HIV/TB integration
3 (2 pre/post, 1 cohort) Serious Not serious Serious Not serious 846 (849) 0.66 (0.39) 2.05 (0.597.09) Very lowc
Provider-initiated HIV testing
2 (1 cohort, 1 pre/post) Serious Serious Serious Not serious 2399 (7237) 0.68 (0.69) 0.91 (0.860.97) Very lowc
Interventions combined with home-based HIV testing
2 (2 cRCT) Not serious Not serious Not serious Serious 8565 (8787) 0.03 (0.01) 2.00 (1.362.92) Lowc
Rapid/point-of-care CD4 count technology
7 (3 pre/post, 2 cohort, 2 iRCT)d Serious Serious Serious Not serious 1524 (1598) 0.50 (0.42) 1.26 (1.021.55) Low
Improved clinic operations
3 (1 iRCT, 1 cRCT, 1 pre/post) Serious Not serious Not serious Not serious 5577 (4052) 0.70 (0.63) 1.36 (1.251.48) Lowb
Package of patient services
3 (1 iRCT, 2 pre/post) Serious Not serious Serious Not serious 731 (277) 0.80 (0.63) 1.54 (1.201.97) Lowb
cRCT, cluster-randomized trial; iRCT, individually randomized trial.
aFour interventions from three studies. As the same control was used for comparison to both interventions in Barnabas 2015, we did not double count the control group in the total control subjects.
bGraded down one level as few studies. cGraded down two levels as few studies and risk of bias. dOne study (Moyo) not included in meta-analysis as no Ns provided and no variance provided.
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with twofold increase in ART initiation compared to non-
integrated care (RR: 2.05; 95% CI: 0.597.09) but with very
poor precision. With only three studies, all of which were
observational, the overall quality of evidence was very low.
Provider-initiated HIV testing
Two studies reported the impact of Provider-Initiated HIV
Counseling and Testing (PITC) on ART initiation, one in South
Africa [15] and one in Zambia [16]. One was a prepost study
and one was a cohort study. They included a total of 9636
subjects. One of the interventions showed a very small
increase and the other a decrease in ART initiation associated
with PITC. Overall ART initiation in the control group was
69%. When the data were combined through meta-analysis,
PITC was the only category of interventions that was
associated with reduced ART initiation (RR: 0.91; 95% CI:
0.860.97). This should be interpreted with caution as the
absolute reduction in ART initiation was only 1%. In addition,
it is important to note here that patients in PITC and those
identified through Voluntary Counseling and Testing (VCT) are
likely different with respect to their disease stage, making it
difficult to draw strong conclusions. As there were only two
studies and all were observational, the overall quality of the
evidence was very low.
Interventions combined with home-based HIV testing
Two cluster-randomized trials examined the effect on ART
initiation of interventions combined with home-based HIV
testing, one in Kenya and one in Malawi. The study in Kenya
compared home-based testing with POC CD4 counts to
home-based testing with standard referral [17]. The study
in Malawi compared home-based testing with optional home
ART initiation to home-based testing with facility-based care
[18]. Both showed a benefit in terms of ART initiation. In our
meta-analysis, home-based testing was associated with an
increase in ART initiation (RR: 2.00; 95% CI: 1.362.92). The
studies included a total of 17,352 subjects, but it is important
to note that the denominator in the Malawi study [18]
included all persons tested, not just those testing HIV positive
or eligible for ART, making overall rates of ART initiation
appear very low. This has a strong influence on the overall
results, as the pooled rate of ART initiation in the control
group was just 0.7%, leading the meta-analysis relative
estimate of a 100% increase in ART initiation to translate
into only a 1.7% absolute increase. While both of the studies
included were randomized controlled trial (RCTs), as there
were only two studies, the overall quality of the evidence
was graded as low.
Rapid POC CD4 count technology
Five observational studies and two randomized trials eval-
uated the effect of rapid/POC CD4 count technology on ART
initiation in South Africa (4), Botswana, Malawi, Mozambique
and Uganda. Five tested the effect of POC testing using Alere
Pima machines [8,19,20,22,29] and two used same day BD
FACS Count results [11,21]. One study did not report the
sample size or a CI for its reported RR so could not be
included in the meta-analysis [22]. The remaining six studies
enrolled 3122 subjects. The pooled rate of ART initiation in
the control group was 42%. Three of the interventions
showed a benefit, while three showed little or no effect. In
our meta-analysis, rapid/POC CD4 count technology was
associated with an increase in ART initiation (RR: 1.26; 95%
CI: 1.021.55). While this category had the largest number of
studies, all but two were observational, and the overall
quality of the evidence was thus considered low.
Improved clinic operations
Two studies conducted in South Africa [23,24] and one in
Mozambique [25] evaluated multi-faceted changes to clinic
operations. The interventions, which were very diverse, are
described in detail in Tables 1 and 2. Each included two or
more of a range of activities: enhanced counselling and
support, task shifting, provider training, POC technology, HIV
service integration, improved clinic management and others.
Two were RCTs (one individually randomized, one cluster
randomized) and one was an observational study. One study
did not report the sample size [25], but for the two remaining,
the total number of subjects was 9629. The pooled rate of ART
initiation in the control group was 63%. All three of the
Counselling and support
HIV/TB integration
Provider initiated HIV testing
Interventions within home based HIV testing
Point of care or rapid CD4 count
Improved clinic operations
Package of patient services
0.1 1 10
Random Effects Relative Risk
Figure 2. Summary relative risks from a random effects meta-analysis of data from each category of intervention.
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interventions increased ART initiation (though one had a
very wide CI) [23]. In our meta-analysis, improved clinic
operations showed a benefit in terms of increased ART
initiation (RR: 1.36; 95% CI: 1.251.48). This result should
be interpreted with caution, however, given the hetero-
geneity of the interventions. The specific mix of activities
included in each intervention may determine its effect, such
that different combinations would produce different re-
sults from those reported here. Overall, the quality of the
evidence was low, as there were only three studies and one
was a prepost design.
Package of patient services
We identified three studies that explored the impact of a
package of patient-directed services. As with the previous
category, each package included two or more services,
described in detail in Tables 1 and 2. One was a prepost
study in Swaziland [26] that tested the effect of a package of
pre-ART services; the second, a prepost study in Uganda
that tested the effect of SMS notification of CD4 results
combined with transport reimbursement [27]; and the third,
a randomized trial in Uganda [28] that tested a package of
enhanced linkage with case-management referral. All three
showed a benefit in terms of treatment initiation. The rate of
ART initiation in the control group was 63%. In our meta-
analysis, the interventions were associated with an increase
in initiation (RR: 1.54; 95% CI: 1.201.97). As there were only
three studies and two were observational, the evidence was
considered low quality.
Discussion
Over the decade of large-scale public sector access to HIV
treatment in sub-Saharan Africa, numerous reviews have
documented losses from the HIV care and treatment cascade
[30], documenting particularly high attrition between HIV
testing and ART initiation [2]. In the light of the World Health
Organization’s recent recommendation that treatment be
offered to all people living with HIV at any CD4 count [31],
the steps needed for patients to access care will change
dramatically, effectively eliminating the interval of ‘‘pre-ART
care’’ during which ineligible patients were monitored for
disease progression. In the new cascade of care that the WHO
recommendations suggest, the most likely points at which
patients who test positive for HIV will become lost to care are
between linkages from an HIV testing site to an HIV treatment
site and between an initial visit to an HIV treatment site and
ART initiation. To inform this new paradigm, we systematically
reviewed the literature on interventions aimed at pre-ART
care but which specifically focused on, or presented data on,
changes in the rate or timing of ART initiation, the outcome
most relevant to this new, simplified cascade of care. We
focused on sub-Saharan Africa as most of the studies we
identified overall were from this region, making it difficult to
generalize to other areas.
Because interventions to improve pre-ART care outcomes
are diverse and heterogeneous, we grouped the interven-
tions into categories representing similar approaches to
improving care. In interpreting the results presented here,
we reiterate that both the interventions included in each
category and the methods used to evaluate them differed
widely, such that any conclusions drawn should be treated
with caution.
While the overall body of evidence was mixed, we found
several approaches that were promising in terms of ART
initiation. Integrating HIV and TB services, whether through
simply co-locating the services, or fully integrating them, was
associated with a roughly twofold increase in rates of ART
initiation among individuals with active TB and living with
HIV. This finding expands upon the conclusions of a previous
2011 review [32], which found benefits from co-locating
services for adherence and retention on ART but provided
little evidence on whether co-location improved ART uptake.
As our results are based on only three studies and low-quality
evidence, and one of the three studies did not find a benefit
for ART initiation, more research on TB/HIV integration inter-
ventions is needed before strong conclusions can be drawn.
Another area that showed promise was the use of rapid
and/or POC CD4 count technology. Use of machines such as
the Alere Pima for rapid CD4 results increases the proportion
of patients who learn that they are eligible for treatment and
reduces the number of visits required to initiate treatment
[33]. As the most recent WHO recommendation to initiate
ART regardless of CD4 count is adopted into national policies,
the CD4 count will lose its primary role in establishing treat-
ment eligibility. Nonetheless, CD4 counts may be retained as
a valuable clinical component of the initiation algorithm in
many countries for years to come, in identification of the
sickest. In the studies reviewed here, use of rapid and/or POC
CD4 count technology was associated with about a 25%
increase in ART initiation (random effects RR 1.26; 95% CI:
1.021.55) compared to standard of care referral for CD4
testing. Offering a POC CD4 count has previously been shown
to be effective at increasing the proportion of patients who
receive their CD4 test results [3335]. Our findings with
regard to ART initiation are in the same direction as, but
smaller than, those of a previous meta-analysis on POC CD4
testing, which reported a RR of 1.8 (95% CI: 1.12.9) [34].
Finally, multi-faceted interventions that improved clinic
operations or offered a package of patient services also
showed promise and perhaps have the most relevance to
future treatment guidelines. Such approaches target more
than one step in the cascade, strengthening both linkage to
care after HIV testing and treatment initiation after linkage.
In these two categories, we found only five studies in total,
but all reported a benefit, with a combined risk ratio of
1.36 (95% CI: 1.251.48) for improved clinic operations and
1.54 (95% CI: 1.202.00) for improvements in the package
of patient services. Although these results agree with data
from other parts of the world and in other patient popu-
lations, the approaches remain diverse and the quality of the
evidence is low. More high-quality studies will be needed
before we draw strong conclusions and discern which specific
components of the interventions might be most important
for achieving results.
Other interventions, including peer and lay counsellor
support and provider-initiated HIV testing, showed little
impact on ART initiation. This is particularly disappointing
for peer and lay counsellor support, which had previously
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been found to be effective at increasing linkage to care [33]
but here had no benefit for ART initiation. PITC, moreover,
appears to be associated with a slight reduction in ART
initiation, though in the light of the low quality of evidence,
at best we can say there appears to be no benefit. PITC
may be identifying patients who do not wish to volunteer
for care and thus increase the denominator (patients who
could start ART) without changing the numerator (patients
who do start ART).
In contrast to the PITC results, the studies reviewed suggest
that interventions within a platform of home-based HIV
testing have promise for increasing ART uptake. This category
does not capture the effects of home-based testing itself but
rather the effects of interventions designed to improve
linkage or ART initiation after home-based testing. The two
interventions included in the review were use of POC CD4
counts to determine treatment eligibility and optional home
ART initiation; both were effective but further evidence will
be needed for each one before general conclusions about
home-based services can be drawn.
Beyond the small number of studies that estimated the
effect of interventions in increasing ART uptake, the overall
quality of the studies was poor. To some extent, the apparent
low quality of the literature reviewed here stems from the
fact that interventions to improve pre-ART care and increase
uptake of ART are largely structural or behavioural. Unlike for
drug trials, results depend heavily on the details of how the
intervention was designed, to whom it was delivered (in
terms of population age, gender, socioeconomic status),
where it was delivered (community, facility level, etc.), which
outcomes were assessed and to what they were compared
(standard of care, another intervention, etc.). In this review,
we found very few reports of studies that evaluated the
effect of the same intervention on the same outcome or
population. For example, a POC CD4 count using the same
technology may have sharply different results in urban and
rural settings or when used at community-based or facility-
based HIV testing sites. For this reason, trying to generalize
from just a few studies  even those of moderate or high
quality  is potentially misleading. For every inter-
vention considered, context  location, population, outcome
and so on  is an essential component of understanding
effectiveness.
In addition to the need for more, and more rigorous,
evaluations of interventions, a consideration that was omit-
ted from nearly all the studies reviewed here is retention
of patients on ART in the immediate aftermath of initiation.
For most researchers examining the pre-ART care period,
ART initiation has been an endpoint with no follow-up to
investigate whether the mode or timing of initiation is
associated with outcomes once treatment has been started.
As the global paradigm for ‘‘pre-ART care’’ evolves, and more
effective ways to move patients from HIV testing to ART
initiation are sought and implemented, studies that assess
not just uptake of ART, but uptake with early retention on
ART, would strengthen the evidence base.
In conclusion, in a systematic review of the literature from
2008 to mid-2016 reporting on interventions to increase
rates of ART initiation in sub-Saharan Africa, we found
only 22 studies. They were diverse in nature, ranging from
counselling or technology interventions focused on one step
in the pre-ART cascade to multi-faceted rearrangements
of how care is provided. Some promising approaches were
identified and merit further research on their effect and cost-
effectiveness in a range of settings and populations. For all
the approaches identified, however, the number of studies
was small and quality mixed. In view of the new global
recommendation of starting all HIV-positive individuals on
ART, rather than attempting to retain those with high CD4
counts in pre-ART care, researchers must invest far more
effort in identifying and evaluating how best to offer treat-
ment initiation in a manner that is both efficient for service
providers and effective for patients, without jeopardizing
treatment outcomes.
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